Antiangiogenesis Combined with Immunotherapy to Treat Advanced Small-Cell Carcinoma of the Esophagus Resistant to Chemotherapy: According to the Guidance of Next-Generation Sequencing-Reference-Cited by-同舟云学术

Antiangiogenesis Combined with Immunotherapy to Treat Advanced Small-Cell Carcinoma of the Esophagus Resistant to Chemotherapy: According to the Guidance of Next-Generation Sequencing

Published:2021-03 Issue: Volume:Volume 14 Page:1613-1621
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Jiang Man,Zhang Xiaochun

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Small cell carcinoma of the esophagus

3. Small Cell Carcinoma of the Esophagus

4. Telomerase activity in small cell esophageal carcinoma

5. Long-term survivors after the resection of limited esophageal small cell carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer;Thoracic Cancer;2024-05-21

2. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma;Journal of Gastrointestinal Oncology;2023-12

3. Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report;World Journal of Clinical Cases;2023-09-26

4. Catequentinib/cisplatin/irinotecan;Reactions Weekly;2022-04